PP
LNAI

Paloma Partners’s Lunai Bioworks LNAI Stock Holding History

Paloma Partners’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-212
Closed -$8.19K – 921
2024
Q3 		$8.19K Buy
+212
New +$14.7K ﹤0.01% 1096
2020
Q4 		– Sell
-227
Closed -$65K – 2123
2020
Q3 		$65K Buy
+227
New +$71.5K ﹤0.01% 1952
2019
Q4 		– Sell
-135
Closed -$59K – 2436
2019
Q3 		$59K Buy
+135
New +$51.6K ﹤0.01% 1870

Other funds holding LNAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paloma Partners's LNAI Position: Q4 2024 in Review

Paloma Partners sold out of Lunai Bioworks (LNAI) in Q4 2024, closing a stake of 212 shares — an estimated $8.19K sold.

Paloma Partners first reported a position in LNAI in Q3 2019 and held it in 3 quarters. The position peaked at $65K in Q3 2020. 56 funds tracked by Wall St. Rank hold LNAI as of Q4 2024.

  • Paloma Partners reported no remaining Lunai Bioworks position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 212 Lunai Bioworks shares in Q4 2024, an estimated $8.19K.
  • Paloma Partners first reported a position in Lunai Bioworks in Q3 2019 and held it in 3 quarters.
  • Paloma Partners's Lunai Bioworks position peaked at $65K in Q3 2020.
  • 56 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.